{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:02:15Z","timestamp":1789527735004,"version":"build-2803163510"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Both imaging and temporal artery biopsy (TAB) are utilized to confirm a suspected diagnosis of giant cell arteritis (GCA). What are the advantages of imaging over TAB?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This article is based on a debate presented at the 21st Vasculitis Meeting, discussing whether imaging or TAB with histology should be the primary diagnostic method for suspected GCA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A suspected diagnosis of GCA should be confirmed or excluded either through imaging or histology. The author advocates for imaging, particularly US, as the initial diagnostic test, in line with EULAR recommendations. Alternatives to US include MRI, CT, and PET, mostly performed in conjunction with CT. Imaging is non-invasive, reliable, sensitive also to extracranial GCA, and specific. Particularly, US is widely available, cost-effective, and patient-friendly. Rheumatologists can perform it promptly during clinical history taking and examination. The introduction of Fast-Track Clinics providing rapid access to specialist care and US has reduced instances of permanent vision loss. The clinical presentation and imaging findings must be conclusive; otherwise, a second diagnostic test should be conducted. This could be another imaging test, such as PET for suspected extracranial GCA, or TAB for suspected cranial GCA. Importantly, the diagnostic process should not delay the initiation of glucocorticoid treatment in suspected GCA cases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>A suspected diagnosis of GCA should be confirmed or excluded via imaging or TAB. Imaging, particularly US, offers several advantages over TAB as the initial diagnostic test.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae487","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T09:18:19Z","timestamp":1741771099000},"page":"i71-i73","source":"Crossref","is-referenced-by-count":6,"title":["Biopsy vs imaging in the diagnosis of giant cell arteritis. Viewpoint 1: in favour of imaging"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7831-8738","authenticated-orcid":false,"given":"Wolfgang Andreas","family":"Schmidt","sequence":"first","affiliation":[{"name":"Immanuel Krankenhaus Berlin, Medical Centre for Rheumatology Berlin-Buch , Berlin,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"2025031209172183600_keae487-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amsu.2017.06.020","article-title":"Temporal artery biopsy in the diagnosis of giant cell arteritis: does the end justify the means?","volume":"20","author":"Bowling","year":"2017","journal-title":"Ann Med Surg"},{"key":"2025031209172183600_keae487-B2","doi-asserted-by":"crossref","first-page":"101847","DOI":"10.1016\/j.berh.2023.101847","article-title":"Vascular ultrasound in rheumatology practice","volume":"37","author":"Schmidt","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2025031209172183600_keae487-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20900","article-title":"The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study","volume":"20","author":"Luqmani","year":"2016","journal-title":"Health Technol Assess"},{"key":"2025031209172183600_keae487-B4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/ard-2023-224543","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update","volume":"83","author":"Dejaco","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2025031209172183600_keae487-B5","doi-asserted-by":"crossref","first-page":"e003379","DOI":"10.1136\/rmdopen-2023-003379","article-title":"Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations","volume":"9","author":"Bosch","year":"2023","journal-title":"RMD Open"},{"key":"2025031209172183600_keae487-B6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00259-018-4021-4","article-title":"Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy","volume":"45","author":"Nielsen","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025031209172183600_keae487-B7","doi-asserted-by":"crossref","first-page":"1759720X241251742","DOI":"10.1177\/1759720X241251742","article-title":"Diagnosing vasculitis with ultrasound: findings and pitfalls","volume":"16","author":"Schmidt","year":"2024","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2025031209172183600_keae487-B8","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/annrheumdis-2021-220306","article-title":"Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: a prospective analysis","volume":"80","author":"Ponte","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2025031209172183600_keae487-B9","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM199711063371902","article-title":"Color duplex ultrasonography in the diagnosis of temporal arteritis","volume":"337","author":"Schmidt","year":"1997","journal-title":"N Engl J Med"},{"key":"2025031209172183600_keae487-B10","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1093\/rheumatology\/kead028","article-title":"Ultrasonography in the assessment of disease activity in cranial and large-vessel giant cell arteritis: a prospective follow-up study","volume":"62","author":"Nielsen","year":"2023","journal-title":"Rheumatology"},{"key":"2025031209172183600_keae487-B11","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/modpathol.2017.10","article-title":"Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients","volume":"30","author":"Maleszewski","year":"2017","journal-title":"Mod Pathol"},{"key":"2025031209172183600_keae487-B12","doi-asserted-by":"crossref","first-page":"1759720X21998505","DOI":"10.1177\/1759720X21998505","article-title":"Ultrasound for diagnosis and follow-up of chronic axillary vasculitis in patients with long-standing giant cell arteritis","volume":"13","author":"Bosch","year":"2021","journal-title":"Ther Adv Musculoskel Dis"},{"key":"2025031209172183600_keae487-B13","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/rheumatology\/kez355","article-title":"The ultrasound halo sign of temporal arteries: is it always giant cell arteritis?","volume":"58","author":"Schmidt","year":"2019","journal-title":"Rheumatology"},{"key":"2025031209172183600_keae487-B14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.5414\/CNP62384","article-title":"Temporal arteritis with pauci-immune glomerulonephritis: a systemic disease","volume":"62","author":"M\u00fcller","year":"2004","journal-title":"Clin Nephrol"},{"key":"2025031209172183600_keae487-B15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/kead189","article-title":"Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica","volume":"63","author":"De Miguel","year":"2024","journal-title":"Rheumatology"},{"key":"2025031209172183600_keae487-B16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard-2023-224768","article-title":"Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica","volume":"83","author":"De Miguel","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2025031209172183600_keae487-B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-024-01532-9","article-title":"Recommendations for defining giant cell arteritis fast-track clinics","author":"Schmidt","year":"2024","journal-title":"Z Rheumatol"},{"key":"2025031209172183600_keae487-B18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/ard-2022-223367","article-title":"The provisional OMERACT ultrasonography score for giant cell arteritis","volume":"82","author":"Dejaco","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025031209172183600_keae487-B19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae056","article-title":"MRVAS Score-introducing a standardized magnetic resonance scoring system for assessing the extent of inflammatory burden in giant cell arteritis","author":"Froehlich","year":"2024","journal-title":"Rheumatology"},{"key":"2025031209172183600_keae487-B20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/art.40379","article-title":"18 F-fluorodeoxyglucose-positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis","volume":"70","author":"Grayson","year":"2018","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/Supplement_1\/i71\/62374931\/keae487.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/Supplement_1\/i71\/62374931\/keae487.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T09:18:25Z","timestamp":1741771105000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/Supplement_1\/i71\/8069405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":20,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2025,3,12]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae487","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,3,1]]}}}